Rimiterol
From Wikipedia, the free encyclopedia
|
Rimiterol
|
|
| Systematic (IUPAC) name | |
| 4-{(S)-hydroxy[(2R)-piperidin-2-yl]methyl}benzene-1,2-diol | |
| Identifiers | |
| CAS number | |
| ATC code | R03 |
| PubChem | |
| Chemical data | |
| Formula | C12H17NO3 |
| Mol. mass | 223.268 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Rimiterol (INN/USAN) is a third-generation β2-agonist.
|
||||||||||||||||||||||||||

